2008
DOI: 10.3171/jns/2008/108/2/0204
|View full text |Cite
|
Sign up to set email alerts
|

Boost Gamma Knife surgery during multimodality management of adult medulloblastoma

Abstract: Object. The aim of this paper was to determine prognostic factors for adult medulloblastoma treated with boost Gamma Knife surgery (GKS) following resection and craniospinal irradiation.Methods. The authors performed a retrospective analysis of 12 adult patients with histologically proven medulloblastoma or supratentorial primitive neuroectodermal tumor who between February 1991 and December 2004 underwent Ն 1 sessions of GKS for posttreatment residual or recurrent tumors (6 tumors in each group). Before GKS, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
1

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(9 citation statements)
references
References 16 publications
(13 reference statements)
0
8
1
Order By: Relevance
“…Only one spinal recurrence was observed after our postoperative treatment. This result is not consistent with other adult medulloblastoma series [2,27,39,44].…”
Section: Discussioncontrasting
confidence: 79%
“…Only one spinal recurrence was observed after our postoperative treatment. This result is not consistent with other adult medulloblastoma series [2,27,39,44].…”
Section: Discussioncontrasting
confidence: 79%
“…They suggested that SRS could be considered as one treatment option for small, locally recurrent medulloblastomas [5]. Germanwala et al [18] reported the results of boosted GKS for adult medulloblastoma or supratentorial PNET during multimodal treatment. Four of 12 patients (33%) had tumor progression locally with or without intracranial metastases.…”
Section: Discussionmentioning
confidence: 99%
“…118 SRS demonstrated safety and efficacy in a small series of 12 adult patients with residual or recurrent disease. 119 …”
Section: Medulloblastoma and Supratentorial Primitive Neuroectodermalmentioning
confidence: 99%